https://www.selleckchem.com/ALK.html
Several institutions have implemented phenobarbital-based pathways for the treatment of alcohol withdrawal syndrome. However, little is known about the care processes, effectiveness, and safety of phenobarbital-based pathways for intensive care unit patients. This study aimed to examine clinician acceptability and feasibility and patient outcomes after the implementation of a phenobarbital-based pathway for medical intensive care unit patients with severe alcohol withdrawal syndrome. We conducted a mixed methods study of a quality improvement interv
Curtir
Comentario
Compartilhar
